Abstract
Objective
To investigate the association between physical activity (PA) and risk of mortality
in a large middle-aged cohort stratified by inflammatory status.
Patients and Methods
A total of 336,560 individuals (mean age, 39.7 years; 58% male) who underwent comprehensive
health screenings were enrolled in this prospective cohort study. They were grouped
according to self-reported PA level using a questionnaire: no regular PA with a sedentary
lifestyle, regular but insufficient PA (below the guidelines), sufficient PA (concordant
with the guidelines), and health-enhancing PA. Inflammation was assessed via high-sensitivity
C-reactive protein (hsCRP) level. Study end points were all-cause, cardiovascular-related,
and cancer-related mortality.
Results
During the 1,976,882 person-years of follow-up (median follow-up duration, 6.17 years),
2062 deaths occurred. Compared with a sedentary lifestyle, the hazard ratios (95%
CIs) on the multivariable Cox proportional hazards regression analyses for all-cause
mortality by PA level were 0.95 (0.84-1.07), 0.85 (0.72-0.99), and 0.75 (0.60-0.93)
(P for trend=.003), and those for cardiovascular- and cancer-related mortality were
0.95, 0.80, and 0.55 (P for trend=.05) and 0.82, 0.83, and 0.78 (P for trend=.01), respectively. Compared with participants with low hsCRP levels and
any regular PA, those with high hsCRP levels and no regular PA had a significantly
higher risk of mortality (1.59 [1.38-1.84]).
Conclusion
Higher PA levels were associated with a dose-dependent reduced risk of cardiovascular-related,
cancer-related, and all-cause mortality. Individuals with high hsCRP levels and no
regular PA had the highest risk of mortality.
Abbreviations and Acronyms:
BMI (body mass index), BP (blood pressure), CVD (cardiovascular disease), HDL-C (high-density lipoprotein cholesterol), HOMA-IR (homeostatic model assessment of insulin resistance), HR (hazard ratio), hsCRP (high-sensitivity C-reactive protein), IPAQ-SF (International Physical Activity Questionnaire Short Form), IQR (interquartile range), LDL-C (low-density lipoprotein cholesterol), MET (metabolic equivalent), PA (physical activity)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Mayo Clinic ProceedingsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Exercise and physical activity: clinical outcomes and applications.Circulation. 2010; 122: 1637-1648
- Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women.JAMA. 1996; 276: 205-210
- Physical fitness and all-cause mortality: a prospective study of healthy men and women.JAMA. 1989; 262: 2395-2401
- The association of changes in physical-activity level and other lifestyle characteristics with mortality among men.N Engl J Med. 1993; 328: 538-545
- Exercise capacity and the risk of death in women: the St James Women Take Heart Project.Circulation. 2003; 108: 1554-1559
- Relationship of leisure-time physical activity and mortality: the Finnish twin cohort.JAMA. 1998; 279: 440-444
- Physical activity, all-cause mortality, and longevity of college alumni.N Engl J Med. 1986; 314: 605-613
- 2008 Physical activity guidelines for Americans.Office of Disease Prevention and Health Promothion, Washington, DC2008
- Global Recommendations on Physical Activity for Health.World Health Organization, Geneva, Switzerland2010
- Physical activity and cancer etiology: associations and mechanisms.Cancer Causes Control. 1998; 9: 487-509
- Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort.Cancer Epidemiol Biomarkers Prev. 2005; 14: 459-466
- Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women.Cancer Causes Control. 2003; 14: 519-529
- A prospective study of physical activity and incident and fatal prostate cancer.Arch Intern Med. 2005; 165: 1005-1010
- Nutrition and physical activity guidelines for cancer survivors.CA Cancer J Clin. 2012; 62: 243-274
- Clinical application of C-reactive protein for cardiovascular disease detection and prevention.Circulation. 2003; 107: 363-369
- C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.Circulation. 1998; 97: 2007-2011
- The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome.J Am Coll Cardiol. 2004; 44: 2003-2007
- C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians.Eur Heart J. 2014; 35: 1809-1816
- Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms.Circulation. 2007; 116: 2110-2118
- Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults.Arch Intern Med. 2002; 162: 1286-1292
- Does exercise reduce inflammation? physical activity and C-reactive protein among U.S. adults.Epidemiology. 2002; 13: 561-568
- Physical activity and cardiovascular mortality risk: possible protective mechanisms?.Med Sci Sports Exerc. 2012; 44: 84-88
- Physical activity and risk of cardiovascular disease events: inflammatory and metabolic mechanisms.Med Sci Sports Exerc. 2009; 41: 1206-1211
- International physical activity questionnaire: 12-country reliability and validity.Med Sci Sports Exerc. 2003; 35: 1381-1395
- Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form.J Korean Acad Fam Med. 2007; 28: 532-541
- Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.Circulation. 2003; 107: 499-511
- C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.Circ Cardiovasc Qual Outcomes. 2008; 1: 92-97
- Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction.Circ Cardiovasc Genet. 2010; 3: 436-444
- Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.JAMA. 2009; 301: 2024-2035
- Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study.Lancet. 2011; 378: 1244-1253
- Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship.JAMA Intern Med. 2015; 175: 959-967
- Physical activity recommendations and decreased risk of mortality.Arch Intern Med. 2007; 167: 2453-2460
- Increased daily movement associates with reduced mortality among COPD patients having systemic inflammation.Int J Clin Pract. 2016; 70: 286-291
- C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study.Eur Heart J. 2005; 26: 1783-1789
- Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.Ann Intern Med. 2009; 151: 496-507
- Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.JAMA. 2012; 308: 788-795
- Physical activity and survival after breast cancer diagnosis.JAMA. 2005; 293: 2479-2486
- Physical activity and survival after diagnosis of invasive breast cancer.Cancer Epidemiol Biomarkers Prev. 2008; 17: 379-386
- American College of Sports Medicine roundtable on exercise guidelines for cancer survivors.Med Sci Sports Exerc. 2010; 42: 1409-1426
- Exercise interventions on health-related quality of life for people with cancer during active treatment.Cochrane Database Syst Rev. 2012; : CD008465
Article Info
Publication History
Published online: October 25, 2016
Footnotes
For editorial comment, see page 1675; for related articles, see pages 1680 and 1693
Identification
Copyright
© 2016 Mayo Foundation for Medical Education and Research